Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Watchlist
Price: 59.345 USD -1.16%
Market Cap: 11.4B USD

Intrinsic Value

The intrinsic value of one BMRN stock under the Base Case scenario is hidden USD. Compared to the current market price of 59.345 USD, Biomarin Pharmaceutical Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

BMRN Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Biomarin Pharmaceutical Inc

Intrinsic Value History
Dive into the past to invest in the future

BMRN looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if BMRN is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about BMRN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BMRN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Biomarin Pharmaceutical Inc.

Explain Valuation
Compare BMRN to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Recent regulatory hurdles for BioMarin’s gene therapy portfolio, including potential FDA delays for innovative treatments like valoctocogene roxaparvovec for hemophilia A, could significantly slow revenue growth and erode investor confidence.

Bull Theses

BioMarin’s deep pipeline in rare genetic disorders, including multiple late-stage gene therapy candidates, positions the company as a leader in high-value, underserved orphan markets, with strong prospects for breakthrough designations.

Show More Less
How do you feel about BMRN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biomarin Pharmaceutical Inc

Current Assets 3.9B
Cash & Short-Term Investments 1.5B
Receivables 790.3m
Other Current Assets 1.6B
Non-Current Assets 3.8B
Long-Term Investments 512.9m
PP&E 1B
Intangibles 429.3m
Other Non-Current Assets 1.8B
Current Liabilities 798.4m
Accounts Payable 389.7m
Accrued Liabilities 354.9m
Other Current Liabilities 53.8m
Non-Current Liabilities 759.7m
Long-Term Debt 596.7m
Other Non-Current Liabilities 163.1m
Efficiency

Free Cash Flow Analysis
Biomarin Pharmaceutical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biomarin Pharmaceutical Inc

Revenue
3.1B USD
Cost of Revenue
-577.9m USD
Gross Profit
2.5B USD
Operating Expenses
-1.9B USD
Operating Income
625.3m USD
Other Expenses
-104.9m USD
Net Income
520.4m USD
Fundamental Scores

BMRN Profitability Score
Profitability Due Diligence

Biomarin Pharmaceutical Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Healthy Operating Margin
hidden
Profitability
Score

Biomarin Pharmaceutical Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BMRN Solvency Score
Solvency Due Diligence

Biomarin Pharmaceutical Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Biomarin Pharmaceutical Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BMRN Price Targets Summary
Biomarin Pharmaceutical Inc

Wall Street analysts forecast BMRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BMRN is 92.078 USD with a low forecast of 55.55 USD and a high forecast of 128.1 USD.

Lowest
Price Target
55.55 USD
6% Downside
Average
Price Target
92.078 USD
55% Upside
Highest
Price Target
128.1 USD
116% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Biomarin Pharmaceutical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BMRN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BMRN Insider Trading
Buy and sell transactions by insiders

BMRN News

Other Videos
What is the Intrinsic Value of one BMRN stock?

The intrinsic value of one BMRN stock under the Base Case scenario is hidden USD.

Is BMRN stock undervalued or overvalued?

Compared to the current market price of 59.345 USD, Biomarin Pharmaceutical Inc is hidden .

Back to Top